The analysis of cellular mechanisms underlying haematopoietic stem cell (HSC) development using a novel in vitro system
使用新型体外系统分析造血干细胞 (HSC) 发育的细胞机制
基本信息
- 批准号:BB/D01347X/1
- 负责人:
- 金额:$ 51.61万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2006
- 资助国家:英国
- 起止时间:2006 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The entire variety of red and white blood cells in mammals is generated by a small number of cells in the bone marrow. In this project we will investigate how blood stem cells are generated in the mammalian embryo. Blood stem cells develop in the area called the AGM region which encompasses a large vessel (the dorsal aorta) and embryonic gonads and kidneys. Two main questions will be asked here: i) what are the cells in the embryo which develop into blood stem cells? and ii) what are the helper cells which induce or facilitate this process? Until recently, owing to lack of an adequate experimental model it has not been possible to address these issues. We have developed an experimental system which allows us to culture and manipulate immature cells from the mouse AGM region and generate blood stem cells. This system will be used to test the ability of different cell types to develop into blood stem cells or to support stem cell formation. To this end different cell types from the embryo will be stained with specific reagents (antibodies) and isolated by a machine called fluorescence-activated cell sorter (FACS). However, certain important cell types cannot be isolated using antibodies. Therefore we will use genetically modified transgenic mice generated in the laboratory. In two such transgenic mouse models AML1 and HoxB4 genes known to be associated with stem cell development are labelled with green and yellow fluorescent reporter molecules. These fluorescent tags will allow us to isolate AML1 and HoxB4 cells by FACS and analyse their ability to develop in stem cells in the culture system. A complementary and important aspect of this project is to investigate the possibility of using our culture system for the generation of blood stem cells from embryonic stem cells (known as ES cells). ES cells can be used to produce entire adult mice. They are thus capable of generating all cell types in the mouse including blood stem cells. In traditional culture conditions previously used by researchers ES cells could only produce mature blood cells but not blood stem cells. Using our novel system by co-culturing ES cells and AGM cells we will be able to determine whether ES cells can generate blood stem cells under the influence of AGM cells. Here again we will isolate cell populations from cultured ES cells by FACS and test them in this system. This project will provide better understanding not only of biology of blood stem cells but also of other stem cells. It will also have important practical implications for generation and propagation of blood stem cells in culture.
哺乳动物的红细胞和白色细胞的全部种类都是由骨髓中的少量细胞产生的。在这个项目中,我们将研究造血干细胞如何在哺乳动物胚胎中产生。血液干细胞在AGM区域发育,该区域包括一个大血管(背主动脉)和胚胎性腺和肾脏。这里有两个主要问题:i)胚胎中发育成造血干细胞的细胞是什么?以及ii)什么是诱导或促进这一过程的辅助细胞?直到最近,由于缺乏适当的实验模型,一直无法解决这些问题。我们已经开发了一个实验系统,使我们能够培养和操纵来自小鼠AGM区域的未成熟细胞,并产生造血干细胞。该系统将用于测试不同类型的细胞发育成血液干细胞或支持干细胞形成的能力。为此,来自胚胎的不同细胞类型将用特定试剂(抗体)染色,并通过称为荧光激活细胞分选仪(FACS)的机器分离。然而,某些重要的细胞类型不能使用抗体分离。因此,我们将使用实验室中产生的转基因小鼠。在两个这样的转基因小鼠模型中,已知与干细胞发育相关的AML 1和HoxB 4基因用绿色和黄色荧光报告分子标记。这些荧光标记将使我们能够通过FACS分离AML 1和HoxB4细胞,并分析它们在培养系统中在干细胞中发育的能力。该项目的一个补充和重要方面是研究使用我们的培养系统从胚胎干细胞(称为ES细胞)产生血液干细胞的可能性。胚胎干细胞可以用来生产完整的成年小鼠。因此,它们能够在小鼠中产生所有类型的细胞,包括造血干细胞。在研究人员以前使用的传统培养条件下,ES细胞只能产生成熟的血细胞,而不能产生造血干细胞。使用我们的新系统,通过共培养ES细胞和AGM细胞,我们将能够确定ES细胞是否可以在AGM细胞的影响下产生造血干细胞。在这里,我们将再次通过流式细胞术从培养的ES细胞中分离细胞群,并在该系统中对其进行测试。该项目不仅将提供对血液干细胞生物学的更好理解,还将提供对其他干细胞生物学的更好理解。这也将对造血干细胞的培养和繁殖具有重要的实际意义。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Analysis and manipulation of hematopoietic progenitor and stem cells from murine embryonic tissues.
- DOI:10.1002/9780470151808.sc02a06s4
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:A. Medvinsky;S. Taoudi;Sandra Mendes;E. Dzierzak
- 通讯作者:A. Medvinsky;S. Taoudi;Sandra Mendes;E. Dzierzak
Runx1 is required for progression of CD41+ embryonic precursors into HSCs but not prior to this.
- DOI:10.1242/dev.110841
- 发表时间:2014-09
- 期刊:
- 影响因子:0
- 作者:Liakhovitskaia A;Rybtsov S;Smith T;Batsivari A;Rybtsova N;Rode C;de Bruijn M;Buchholz F;Gordon-Keylock S;Zhao S;Medvinsky A
- 通讯作者:Medvinsky A
Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region.
- DOI:10.1084/jem.20111688
- 发表时间:2011-11-21
- 期刊:
- 影响因子:0
- 作者:Ivanovs A;Rybtsov S;Welch L;Anderson RA;Turner ML;Medvinsky A
- 通讯作者:Medvinsky A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander Medvinsky其他文献
3074 – SINGLE CELL TRANSCRIPTOMIC ANALYSIS COMBINED WITH MACHINE LEARNING IDENTIFIES HSC-LIKE CELLS DIFFERENTIATED IN VITRO FROM HUMAN IPSCS.
- DOI:
10.1016/j.exphem.2020.09.090 - 发表时间:
2020-08-01 - 期刊:
- 影响因子:
- 作者:
Antonella Fidanza;Patrick Stumpf;Prakash Ramachandran;Helen Taylor;Sara Tamagno;Ann Babtie;Alexander Medvinsky;Katrin Ottersbach;Nicola Romano;Lesley Forrester - 通讯作者:
Lesley Forrester
Fusion brings down barriers
融合消除了障碍
- DOI:
10.1038/422823a - 发表时间:
2003-04-24 - 期刊:
- 影响因子:48.500
- 作者:
Alexander Medvinsky;Austin Smith - 通讯作者:
Austin Smith
Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies
- DOI:
10.1182/blood-2015-09-669036 - 发表时间:
2016-04-14 - 期刊:
- 影响因子:
- 作者:
Cristina Mirantes;Maria Alba Dosil;David Hills;Jian Yang;Núria Eritja;Maria Santacana;Sònia Gatius;Felip Vilardell;Alexander Medvinsky;Xavier Matias-Guiu;Xavier Dolcet - 通讯作者:
Xavier Dolcet
Analysis of notch signalling activity during hematopoietic stem cell development
- DOI:
10.1016/j.exphem.2015.06.131 - 发表时间:
2015-09-01 - 期刊:
- 影响因子:
- 作者:
Javier Gonzalez;Javier G. Lendinez;Celine Souilhol;Stanislav Rybtsov;David Hills;Suling Zhao;Alexander Medvinsky - 通讯作者:
Alexander Medvinsky
3004 – IDENTIFICATION AND CHARACTERIZATION OF NOVEL FUNCTIONAL MARKERS DURING THE HEMATOPOIETIC STEM CELL SPECIFICATION PROCESS
- DOI:
10.1016/j.exphem.2020.09.026 - 发表时间:
2020-08-01 - 期刊:
- 影响因子:
- 作者:
Marleen Büchler-Schäff;Paul Kaschutnig;Roshana Thambyrajah;Wiebke Nadler;Sabrina Hanke;Stella Pfaffenholz;Milena Block;Julius Gräsel;Jakob Kremer;Irem Bayindir-Buchhalter;Wenjun Chang;David Hills;Richard Harbottle;Chrisoph Rösli;Alexander Medvinsky;Michéle Souyri;Georges Lacaud;Michael Milsom - 通讯作者:
Michael Milsom
Alexander Medvinsky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander Medvinsky', 18)}}的其他基金
Validation of biomarkers predicting clinical outcomes of umbilical cord blood transplantation
预测脐带血移植临床结果的生物标志物的验证
- 批准号:
MR/W029669/1 - 财政年份:2023
- 资助金额:
$ 51.61万 - 项目类别:
Research Grant
Analysis of biomechanical forces in the embryonic development of haematopoietic stem cells
造血干细胞胚胎发育过程中的生物力学力分析
- 批准号:
BB/W003236/1 - 财政年份:2022
- 资助金额:
$ 51.61万 - 项目类别:
Research Grant
UNDERSTANDING MOLECULAR MECHANISMS UNDERLYING DEVELOPMENT OF HIGHLY REGENERATIVE HUMAN HAEMATOPOIETIC STEM CELLS
了解高度再生人类造血干细胞发育的分子机制
- 批准号:
MR/V030043/1 - 财政年份:2021
- 资助金额:
$ 51.61万 - 项目类别:
Research Grant
IDENTIFICATION OF A NOVEL ANGIOPOIETIN 2 SIGNALLING CENTRE IN THE EMBRYONIC HAEMATOPOIETIC STEM CELL NICHE
胚胎造血干细胞生态位中新型血管生成素 2 信号中心的鉴定
- 批准号:
MR/R018081/1 - 财政年份:2018
- 资助金额:
$ 51.61万 - 项目类别:
Research Grant
Tracking the embryonic origin of the adult haematopoietic system
追踪成人造血系统的胚胎起源
- 批准号:
MR/L018160/1 - 财政年份:2014
- 资助金额:
$ 51.61万 - 项目类别:
Research Grant
DEVELOPMENT OF A NON-INVASIVE STRATEGY ENHANCING HAEMATOPOIETIC STEM CELL (HSC) POTENTIAL OF HUMAN UMBILICAL CORD CELLS
开发增强人类脐带细胞造血干细胞 (HSC) 潜力的非侵入性策略
- 批准号:
G0901577/1 - 财政年份:2011
- 资助金额:
$ 51.61万 - 项目类别:
Research Grant
Identification of functional domains in the AGM region linked to the hierarchical organisation of the developing haematopoietic stem cell lineage
鉴定与发育中的造血干细胞谱系的层次结构相关的 AGM 区域的功能域
- 批准号:
BB/H008780/1 - 财政年份:2010
- 资助金额:
$ 51.61万 - 项目类别:
Research Grant
ANALYSIS OF MECHANISMS OF EARLY HAEMATOPOIETIC STEM CELL DEVELOPMENT CONTROLLED BY FLK1/SCL REGULATORY NETWORK
FLK1/SCL调控网络调控早期造血干细胞发育机制分析
- 批准号:
G0900962/1 - 财政年份:2010
- 资助金额:
$ 51.61万 - 项目类别:
Research Grant
Role of AML1/Runx1 isoforms in development, self-renewal and differentiation of haematopoietic progenitor/stem cells
AML1/Runx1亚型在造血祖细胞/干细胞发育、自我更新和分化中的作用
- 批准号:
G0500950/1 - 财政年份:2006
- 资助金额:
$ 51.61万 - 项目类别:
Research Grant
相似国自然基金
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
- 批准号:82371144
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
rhTβ4增强间充质干细胞调节T细胞代谢重塑治疗干眼的机制研究
- 批准号:32000530
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
胰岛素和细菌信号协同调节巨噬细胞免疫反应的作用
- 批准号:92057105
- 批准年份:2020
- 资助金额:89.0 万元
- 项目类别:重大研究计划
聚谷氨酰胺(PolyQ)疾病致病蛋白构象多态性的研究及应用
- 批准号:31970748
- 批准年份:2019
- 资助金额:60.0 万元
- 项目类别:面上项目
MAPK11通过RNA结合蛋白ELAVL1调控HTT水平的机制与病理意义研究
- 批准号:31970747
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
细胞代谢重组过程中蛋白质组热稳定性分析
- 批准号:31970706
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
Atg4B可逆氧化修饰的作用机制及其对自噬的调节研究
- 批准号:31970699
- 批准年份:2019
- 资助金额:50.0 万元
- 项目类别:面上项目
用识别EBV相关淋巴瘤抗原多肽的T细胞受体做转基因免疫治疗
- 批准号:81041002
- 批准年份:2010
- 资助金额:10.0 万元
- 项目类别:专项基金项目
半群代数和半群表示
- 批准号:10961014
- 批准年份:2009
- 资助金额:18.0 万元
- 项目类别:地区科学基金项目
Cellular & Molecular Immunology
- 批准号:30824806
- 批准年份:2008
- 资助金额:20.0 万元
- 项目类别:专项基金项目
相似海外基金
EGF Receptor Endocytosis: Mechanisms and Role in Signaling
EGF 受体内吞作用:机制及其在信号传导中的作用
- 批准号:
10552100 - 财政年份:2023
- 资助金额:
$ 51.61万 - 项目类别:
Defining the mechanisms by which mutations in DNAJC7 increase susceptibility to ALS/FTD
确定 DNAJC7 突变增加 ALS/FTD 易感性的机制
- 批准号:
10679697 - 财政年份:2023
- 资助金额:
$ 51.61万 - 项目类别:
Elucidating mechanisms of cellular communication critical for head and neck cancer progression and metastasis.
阐明对头颈癌进展和转移至关重要的细胞通讯机制。
- 批准号:
10752228 - 财政年份:2023
- 资助金额:
$ 51.61万 - 项目类别:
Using new Next Generation Sequencing (NGS) approaches to analyze the fidelity of HIV reverse transcription in Endogenous Reverse Transcription reactions (ERT)
使用新的下一代测序 (NGS) 方法来分析内源性逆转录反应 (ERT) 中 HIV 逆转录的保真度
- 批准号:
10759845 - 财政年份:2023
- 资助金额:
$ 51.61万 - 项目类别:
Mechanisms of New-Onset Autoimmunity/Longitudinal Immune Systems Analysis (MONA-LISA)
新发自身免疫/纵向免疫系统分析(MONA-LISA)的机制
- 批准号:
10655219 - 财政年份:2023
- 资助金额:
$ 51.61万 - 项目类别:
Mechanisms of REST-mediated immunosuppression in cancer
REST 介导的癌症免疫抑制机制
- 批准号:
10749289 - 财政年份:2023
- 资助金额:
$ 51.61万 - 项目类别:
Mechanisms of mitochondrial-ER communication during dietary and thermal induced stress
饮食和热应激期间线粒体-内质网通讯的机制
- 批准号:
10663603 - 财政年份:2023
- 资助金额:
$ 51.61万 - 项目类别:
Identifying New Therapeutics and Molecular Mechanisms in Congenital Disorders of Glycosylation.
确定先天性糖基化疾病的新疗法和分子机制。
- 批准号:
10644811 - 财政年份:2023
- 资助金额:
$ 51.61万 - 项目类别:
Investigating epigenetic mechanisms in Down syndrome using human cellular models
使用人类细胞模型研究唐氏综合症的表观遗传机制
- 批准号:
10655152 - 财政年份:2023
- 资助金额:
$ 51.61万 - 项目类别:
MAGIC tools for genome-wide mosaic analysis with existing Drosophila resources (Equipment Supplement 2023)
利用现有果蝇资源进行全基因组嵌合分析的 MAGIC 工具(设备补充资料 2023)
- 批准号:
10808546 - 财政年份:2023
- 资助金额:
$ 51.61万 - 项目类别: